Solei Systems, Inc. (OTCPK:SOLI) entered into a binding letter of intent to acquire assets of KB Medical Systems, LLC for $2 million on January 7, 2019. As of February 20, 2019, Solei Systems, Inc. (OTCPK:SOLI) entered into a definitive agreement to acquire assets of KB Medical Systems, LLC. The consideration consists of $1 million in cash and issuance of unregistered and restricted common stock of SOLI with a value of $1 million. SOLI will make an additional $5 million in capital contributions to the business of KB known as CareClix after the acquisition. It is contemplated that the acquisition will consist of the acquisition of all of the business, assets and subsidiaries of KB Medical Systems, LLC, including CareClix. The transaction is subject to execution by each Party of the agreement, approval of the agreement and the acquisition by the Members of KB Medical Systems in compliance with applicable state corporate law and federal and state securities laws, delivery of the consideration to KB Medical Systems free of liabilities, completion of the acquisition and transfer of the assets to the newly formed subsidiary of SOLI, including all required regulatory compliance and completion of due diligence to the satisfaction of SOLI. If the agreement has not been approved and executed by the Board of Directors of SOLI, by KB and by the members of KB, on or before January 31, 2019, the letter of intent shall expire and the transactions as anticipated hereunder shall be deemed to have expired without execution, unless otherwise agreed to in writing by the parties. Closing shall take place within 10 days after the completion of due diligence as specified in the agreement, and the satisfaction of all conditions to closing in the agreement, including all regulatory compliance requirements, but in no case later than March 31, 2019, unless otherwise agreed by the parties. Solei Systems, Inc. (OTCPK:SOLI) completed the acquisition of assets of KB Medical Systems, LLC on April 14, 2019.